Reversed-phase HPLC raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-20 and is reviewed periodically as new material appears.
Material supplied for laboratory use is normally a lyophilised white to off-white powder that dissolves readily in water and in isotonic saline. Lyophilised cakes are hygroscopic and should be equilibrated to room temperature before opening to limit condensation on the solid. Solutions are typically prepared at milligram-per-millilitre concentrations and divided into single-use aliquots, because repeated freeze–thaw cycles degrade short peptides. Aqueous solutions are far less stable than the dry powder, and identity is usually verified by mass spectrometry alongside purity estimation from reversed-phase high-performance liquid chromatography.
Epitalon is a synthetic linear tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and the calculated mass is approximately 390.35 g/mol. The compound is made by solid-phase peptide synthesis rather than extracted from tissue, although early work described it as a short fragment of a peptide fraction obtained from bovine pineal extract. In the research literature the spelling epitalon and the variant epithalone both appear, while AEDG is the standard code used in peptide nomenclature.
Storage and handling follow conventional peptide practice. Lyophilized epitalon is typically kept refrigerated or frozen, protected from moisture and light, and allowed to equilibrate to room temperature before opening to avoid condensation. Once dissolved, aqueous solutions are usually stored cold and used within a short period, since dilute peptide solutions can support microbial growth and may slowly degrade. The absence of cysteine and methionine reduces, but does not eliminate, oxidation concerns during long-term storage.
Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.
Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.
| Property | Value | Notes |
|---|---|---|
| Amino acid sequence | Ala-Glu-Asp-Gly | Linear tetrapeptide, also written AEDG |
| Molecular mass | About 390.35 g/mol | Value calculated from the sequence |
| Appearance | White to off-white powder | Lyophilised material forms a loose cake |
| Solubility | Freely soluble in water | Also dissolves in isotonic saline |
| Storage | -20 °C, desiccated | Aliquot solutions to avoid freeze–thaw cycling |
Interest in epitalon is usually discussed within the broader field of short peptide bioregulators, a category that includes other synthetic di-, tri-, and tetrapeptides studied by the same research group. These compounds share a common rationale: that small fragments of tissue-derived proteins can retain biological activity and can be produced reproducibly. The category as a whole remains outside mainstream pharmacological consensus, and epitalon specifically has a limited presence in independent, non-Russian research literature, which shapes how its evidence base is described.
Epitalon is a synthetic tetrapeptide with the amino acid sequence alanine-glutamate-aspartate-glycine, abbreviated Ala-Glu-Asp-Gly or AEDG. It was developed by the Russian researcher Vladimir Khavinson and colleagues during work on peptide bioregulators derived from the pineal gland. The compound is short enough to be produced by standard solid-phase peptide synthesis and is typically handled as a lyophilized white powder. Its small size distinguishes it from larger pineal peptides such as epithalamin, a complex extract from which the tetrapeptide was conceptually derived.
The four residues give epitalon a molecular formula of C14H22N4O9 and a molecular weight near 390.35 daltons. The presence of two acidic residues, glutamate and aspartate, makes the free peptide strongly acidic, while the alanine and glycine ends provide neutral, nonpolar character. This combination produces a molecule with substantial water solubility. Because there are no cysteine, methionine, or tryptophan residues, the peptide lacks the most common oxidation-sensitive side chains, which simplifies handling compared with many longer peptides.
Identity testing for epitalon relies on reversed-phase high-performance liquid chromatography for purity and mass spectrometry for mass confirmation. Because the sequence contains no tryptophan or tyrosine, ultraviolet detection at 280 nanometres is insensitive, so chromatographic methods usually monitor absorbance near 214 nanometres, where the peptide backbone absorbs. Electrospray ionisation or matrix-assisted laser desorption/ionisation then checks the intact mass against the expected value near 390 daltons. Peptide mapping or amino acid analysis after acid hydrolysis can supplement these measurements, although such confirmatory work is seldom reported on commercial certificates of analysis.
Stability of the tetrapeptide follows ordinary peptide chemistry rather than any unusual structural feature. The aspartate-glycine pair is prone to aspartimide formation under mildly basic or neutral conditions, and deamidation can follow, altering both mass and chromatographic retention. Dry lyophilised powder kept at or below minus twenty degrees Celsius is the usual handling recommendation, with repeated freeze-thaw cycles avoided. Once dissolved in neutral aqueous buffer, degradation proceeds over days to weeks depending on pH and temperature, while acidic conditions generally slow the aspartimide route. A formal stability-indicating study has not been published in the indexed literature.
Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.
The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.
Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.
. This tensor may be expressed as the sum of the viscous stress tensor minus the hydrostatic pressure. The negative of the stress tensor is sometimes called the pressure tensor, but in the following, the term "pressure" will refer only to the scalar pressure. According to the theory of general relativity, pressure increases the strength of a gravitational field (see stress–energy tensor) and so adds to the mass-energy cause of gravity. This effect is unnoticeable at everyday pressures but is significant in neutron stars, although it has not been experimentally tested.
Born in Algeria, Sebagh obtained a medical degree from the University of Paris and then learned plastic surgery in Los Angeles. For around 15 years, he worked to rebuild cancer victims' faces and heal burns victims' scarring in Paris's Hôpital Foch. In 1997, he divorced his wife, a Parisian dentist. He has a son and a daughter. Sebagh has a line of skin care products called Dr. Sebagh Anti-Aging marketed by Californian-based direct sales company Guthy-Renker and promoted through TV infomercials.
Information technology, particularly optical fiber and optical amplifiers, allowed for simple and fast long-distance communication, which ushered in the Information Age and the birth of the Internet. The Space Age began with the launch of Sputnik 1 in 1957, and later the launch of crewed missions to the moon in the 1960s. Organized efforts to search for extraterrestrial intelligence have used radio telescopes to detect signs of technology use, or technosignatures, given off by alien civilizations. In medicine, new technologies were developed for diagnosis (CT, PET, and MRI scanning), treatment (like the dialysis machine, defibrillator, pacemaker, and a wide array of new pharmaceutical drugs), and research (like interferon cloning and DNA microarrays). Complex manufacturing and construction techniques and organizations are needed to make and maintain more modern technologies, and entire industries have arisen to develop succeeding generations of increasingly more complex tools. Modern technology increasingly relies on training and education – their designers, builders, maintainers, and users often require sophisticated general and specific training. Moreover, these technologies have become so complex that entire fields have developed to support them, including engineering, medicine, and computer science; and other fields have become more complex, such as construction, transportation, and architecture.
Historically Druzes, by large, sent their children to Protestant schools and accepted an implicit orientation toward Britain. Many of the first graduates of the Syrian Protestant College in Beirut, the forerunner of AUB, were Druze, who over generations maintain an affinity to AUB. At the Catholic schools and universities (such as Notre Dame University–Louaize) in Lebanon, Christian and Druze students study and socialise together. Moreover, many members of the Druze political and cultural elite received their education in Christian institutions. Notable Druze figures who studied at these institutions include Abbas Halabi, Asad Al Faqih, Majid Arslan, Marwan Hamadeh, Manal Abdel Samad, and Kamal Jumblatt, who attended the prestigious Collège Saint Joseph – Antoura. Marriage outside the Druze faith is rare and is strongly discouraged, and Druze can face serious social consequences if he or she converts to another faith to marry a non-Druze. According to Simon Haddad of Notre Dame University–Louaize "if a Druze marries a Christian or Muslim, they could both be ostracized and marginalized by their community, and this could have very serious consequences if the couple works in town". While according to United Nations High Commissioner for Refugees report: "Conversely, a source contacted by the Research Directorate of Canada's Immigration and Refugee Board in September 1998 advised that "there would be no problem for a mixed Druze/Orthodox Christian couple to live a normal life in Lebanon today"".
For generic manufacturers, the act created a new approval mechanism, the Abbreviated New Drug Application (ANDA), in which the generic drug manufacturer need only demonstrate that their generic formulation has the same active ingredient, route of administration, dosage form, strength, and pharmacokinetic properties ("bioequivalence") as the corresponding brand-name drug. This act has been credited with, in essence, creating the modern generic drug industry. Concerns about the length of the drug approval process were brought to the fore early in the AIDS epidemic. In the mid and late 1980s, ACT-UP and other HIV activist organizations accused the FDA of unnecessarily delaying the approval of medications to fight HIV and opportunistic infections. Partly in response to these criticisms, the FDA issued new rules to expedite approval of drugs for life-threatening diseases, and expanded pre-approval access to drugs for patients with limited treatment options. All of the initial drugs approved for the treatment of HIV/AIDS were approved through these accelerated approval mechanisms. Frank Young, then commissioner of the FDA, was behind the Action Plan Phase II, established in August 1987 for quicker approval of AIDS medication. In two instances, state governments have sought to legalize drugs that the FDA has not approved.
Sources: en.wikipedia.org
==== Type IIs restriction endonuclease assembly ==== Some assembly methods also make use of type IIs restriction endonucleases. These differ from other type II endonucleases as they cut several base pairs away from the recognition site. As a result, the overhang sequence can be modified to contain the desired sequence. This provides Type IIs assembly methods with two advantages – it enables "scar-less" assembly, and allows for one-pot, multi-part assembly. Assembly methods that use type IIs endonucleases include Golden Gate and its associated variants.
The amount of opiates can be high provided that the end product is not overly diluted during production, but the amount of diacetylmorphine and 6-monoacetylmorphine created depends on the skills of people making it and the time and conditions of acetylation. The use of the term kompot or compote refers euphemistically to kompot, a traditional, non-alcoholic drink popular in Central and Eastern European countries made by boiling fruit and spices. The so-called kompot method of making a crude opiate "cocktail" intended for injection involves stewing the pods of the opium poppy in nearly boiling water and an acid, and using the strained liquid (essentially like kompot is produced from the raw ingredients). However, in 1976 two Polish students from Gdańsk discovered a simple way of making it by extracting opiate alkaloids from poppy straw by using ion-exchange resin, acetone, ammonia water and a few other chemicals used in the last step of production. In this method, opium poppy pods and stems are boiled in water for a few hours without adding acid, and then filtered. Strongly acidic ion-exchange resin is then added. The resin is filtered and the opiates are recovered with the addition of ammonia water. The resulting liquid is evaporated using a chemical condenser, then when dry (it is then called glazura - glaze) it is acetylated using acetic anhydride in an anhydrous environment of a non-polar solvent, for example toluene, diethyl ether, chloroform, or most commonly acetone.
== History == Mycophenolic acid was discovered by Italian medical scientist Bartolomeo Gosio. Gosio collected a fungus from spoiled corn and named it Penicillium glaucum. (The species is now called P. brevicompactum.) In 1893 he found that the fungus had antibacterial activity. In 1896 he isolated crystals of the compound, which he successfully demonstrated as the active antibacterial compound against the anthrax bacterium. This was the first antibiotic that was isolated in pure and crystalline form. But the discovery was forgotten. It was rediscovered by two American scientists C.L. Alsberg and O.M. Black in 1912, and given the name mycophenolic acid. The compound was eventually demonstrated to have antiviral, antifungal, antibacterial, anticancer, and antipsoriasis activities. Although it is not commercialised as antibiotic due to its adverse effects, its modified compound (ester derivative) is an approved immunosuppressant drug in kidney, heart, and liver transplantations, and is marketed under the brands Cellcept (mycophenolate mofetil by Roche) and Myfortic (mycophenolate sodium by Novartis). Cellcept was developed by a South African geneticist Anthony Allison and his wife Elsie M. Eugui. In the 1970s while working at the Medical Research Council, Allison investigated the biochemical causes of immune deficiency in children. He discovered the metabolic pathway involving an enzyme, inosine monophosphate dehydrogenase, which is responsible for undesirable immune response in autoimmune diseases, as well as for immune rejection in organ transplantation.
=== Policy === Since the mid-1980s pharmaceutical companies have invested in medications for cancer or chronic disease that have greater potential to make money and have "de-emphasized or dropped development of antibiotics". On 20 January 2016 at the World Economic Forum, "80 pharmaceutical and diagnostic companies" called for "transformational commercial models" at an international level to spur research and development on antibiotics and on the use of diagnostic tests. A number of countries are considering or implementing delinked payment models for new antimicrobials whereby payment is based on value rather than volume of drug sales. This offers the opportunity to pay for valuable new drugs even if they are reserved for use in relatively rare drug resistant infections.
Sources: en.wikipedia.org
Iran has faced severe food inflation in the past decade, driven by multiple factors. These include agricultural, climatic and energy challenges, significant issues in water management, and inefficiencies in the food supply chain. A major contributing factor is the involvement of the Iranian Revolutionary Guard Corps (IRGC) in the economy, particularly in the agriculture and food sectors but also due to significant spendings on Iran's proxies which increase the public deficit. The IRGC’s influence has been linked to mismanagement and corruption, exacerbating problems in water resources, agricultural practices, and food production.
== Early life and military service == Jerome Kalman Sherman was born in 1925 in Brooklyn, New York, to Murray and Beatrice Sherman, a sailmaker and Navy Yard worker. After graduating from Erasmus Hall High School early, he enrolled at Brooklyn College at the age of 16, but after three semesters put his studies on hold to enlist in the military during World War II. At age 17, in 1943, Sherman joined the U.S. Navy as a seaman and earned a commission at Notre Dame. He then served in the Pacific Theater as an anti-submarine officer until 1945, learning of the Japanese surrender on his 20th birthday. Subsequently he served in occupied Japan as part of the first naval line officer to enter Nagasaki, left the Navy as a lieutenant commander.
Duane W, Hastings JW (1975). "Flavin mononucleotide reductase of luminous bacteria". Mol. Cell. Biochem. 6 (1): 53–64. doi:10.1007/BF01731866. PMID 47604. Fisher J, Spencer R, Walsh C (1976). "Enzyme-catalyzed redox reactions with the flavin analogues 5-deazariboflavin, 5-deazariboflavin 5'-phosphate, and 5-deazariboflavin 5'-diphosphate, 5' leads to 5'-adenosine ester". Biochemistry. 15 (5): 1054–64. doi:10.1021/bi00650a016. PMID 3207. Tu SC, Becvar JE, Hastings JW (1979). "Kinetic studies on the mechanism of bacterial NAD(P)H:flavin oxidoreductase". Arch. Biochem. Biophys. 193 (1): 110–6. doi:10.1016/0003-9861(79)90013-4. PMID 222213. Liu M, Lei B, Ding Q, Lee JC, Tu SC (1997). "Vibrio harveyi NADPH:FMN oxidoreductase: preparation and characterization of the apoenzyme and monomer-dimer equilibrium". Arch. Biochem. Biophys. 337 (1): 89–95. doi:10.1006/abbi.1996.9746. PMID 8990272. Lei B, Tu SC (1998). "Mechanism of reduced flavin transfer from Vibrio harveyi NADPH-FMN oxidoreductase to luciferase". Biochemistry. 37 (41): 14623–9. doi:10.1021/bi981841+. PMID 9772191. Tang CK, Jeffers CE, Nichols JC, Tu SC (2001). "Flavin specificity and subunit interaction of Vibrio fischeri general NAD(P)H-flavin oxidoreductase FRG/FRase I". Arch. Biochem. Biophys. 392 (1): 110–6. doi:10.1006/abbi.2001.2396. PMID 11469801. Ingelman M, Ramaswamy S, Niviere V, Fontecave M, Eklund H (1999). "Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli". Biochemistry. 38 (22): 7040–9. doi:10.1021/bi982849m. PMID 10353815. Eichhorn E, van der Ploeg JR, Leisinger T (1999).
Sources: en.wikipedia.org
It is a synthetic tetrapeptide. Its sequence was derived from research on peptide fractions of bovine pineal extract, and the intact AEDG sequence has not been demonstrated as an abundant free peptide in human tissue.
AEDG is the one-letter code for the four amino acids alanine, glutamate, aspartate and glycine in that order. The same molecule is written in three-letter form as Ala-Glu-Asp-Gly.
Identity is normally confirmed by mass spectrometry against the calculated mass of roughly 390.35 g/mol. Purity is then estimated by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Identity is normally confirmed by mass spectrometry, which checks the measured mass against the expected value near 390 daltons. Reverse-phase high-performance liquid chromatography is used alongside it to assess purity. Amino acid analysis can provide additional composition data.